DAVID JOHN GRAINGER - CAMBRIDGE
DAVID JOHN GRAINGER - CAMBRIDGE
.
Overview
DAVID JOHN GRAINGER is a Company Director from Cambridge. This person was born in October 1966, which was over 57 years ago. DAVID JOHN GRAINGER is British and resident in England. This company officer is, or was, associated with at least 22 company roles.
Their most recent appointment, in our records, was to LOCKBODY THERAPEUTICS LTD on 2021-11-30, from which they resigned on 2023-08-18.
Address
The Dorothy Hodgkin Building, Babraham Research Campus
Cambridge
CB22 3FH
United Kingdom
Map
Company Appointments - Current and Previous
| CompanyName | Company Status | Role | Appointed | Appointment Status | Assets |
|---|---|---|---|---|---|
| LOCKBODY THERAPEUTICS LTD | Active | Director | 2021-11-30 until 2023-08-18 | RESIGNED | £932,604 cash, £-1,759,462 equity |
| CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED | Active | Director | 2021-11-30 until 2023-08-18 | RESIGNED | £3,042,378 cash, £3,578,170 equity |
| JANPIX LIMITED | Dissolved - no longer trading | Director | 2021-11-30 until 2023-08-18 | RESIGNED | £6,844,993 cash, £7,010,510 equity |
| ULTRAHUMAN FOUR LIMITED | Dissolved - no longer trading | Director | 2021-11-30 until 2023-08-18 | RESIGNED | £89,072 cash, £-158,716 equity |
| CENTESSA PHARMACEUTICALS (OREXIA) LIMITED | Active | Director | 2021-11-30 until 2023-08-18 | RESIGNED | £1,522,790 cash, £2,338,225 equity |
| INEXIA LIMITED | Dissolved - no longer trading | Director | 2021-11-30 until 2023-08-18 | RESIGNED | £851,910 cash, £3,295,751 equity |
| ULTRAHUMAN TWO LIMITED | Dissolved - no longer trading | Director | 2021-11-30 until 2023-08-18 | RESIGNED | £19,660 cash, £-118,625 equity |
| BHE DENEB LTD | Active | Director | 2021-06-14 | CURRENT | £3,966 cash, £-382 equity |
| BPLETE LIMITED | Active | Director | 2021-06-04 | CURRENT | £1 cash, £1 equity |
| A BIO LIMITED | Active | Director | 2021-04-21 | CURRENT | £100 cash, £100 equity |
| BHE ALTAIR LTD | Active | Director | 2021-04-03 | CURRENT | £100 cash, £-84,427 equity |
| BHE BETELGEUSE LTD | Active | Director | 2021-04-03 | CURRENT | £5,891 cash, £8,776 equity |
| BHE CAPELLA LTD | Active | Director | 2021-04-03 | CURRENT | £100 cash, £-1,000 equity |
| BARKWAY HOUSE ESTATES LIMITED | Active | Director | 2021-04-01 | CURRENT | £100 cash, £100 equity |
| PERFECT BALANCE BIO LIMITED | Active | Director | 2020-09-17 | CURRENT | |
| SDS THERAPEUTICS LIMITED | Active | Director | 2020-07-05 until 2024-01-17 | RESIGNED | £2,773,300 cash, £2,765,631 equity |
| IMHOTEX LIMITED | Active | Director | 2020-02-05 | CURRENT | £757,174 cash, £858,549 equity |
| HYDROGEN THERAPEUTICS LIMITED | Active | Director | 2019-09-25 | CURRENT | £46,187 cash, £56,224 equity |
| PANDEIA THERAPEUTICS LIMITED | Active | Director | 2019-09-19 until 2022-12-22 | RESIGNED | £796,269 cash, £829,602 equity |
| ROUND EARTH THERAPEUTICS LIMITED | Liquidation | Director | 2019-08-08 | CURRENT | £713,308 cash, £894,941 equity |
| LITHIUM TX LIMITED | Active | Director | 2019-06-24 | CURRENT | £215 cash, £-2,347 equity |
Related People
| Name | Occupation | Address | No of Appointments |
|---|---|---|---|
| MR FRANCESCO DE RUBERTIS | Venture Capitalist | Altrincham, United Kingdom | 18 |
| MR TIMOTHY SCHULZ-UTERMOEHL | Consultant | Lymm, United Kingdom | 10 |
| DR FRASER MURRAY | Chief Executive | Lymm, England | 8 |
| DR MARIO ALBERTO ACCARDI | Director | London, United Kingdom | 10 |
| DR KEVIN STUART JOHNSON | Venture Capital Investor | Mayfair, England | 29 |
| DR JAMES EDWARD COLEMAN | Director | Sandwich, United Kingdom | 18 |
| WILLIAM JAMES JONATHAN FINLAY | Director | Sandwich, United Kingdom | 15 |
| MR JON EDWARDS | Investor | London, United Kingdom | 13 |
| MR JON EDWARDS | Investor | Sandwich, United Kingdom | 1 |
| DR MARTIN QUIBELL | Scientist | Macclesfield, England | 3 |
| MR FRANCESCO DE RUBERTIS | Investor | Cambridge, United Kingdom | 1 |
| MR IQBAL HUSSAIN | Lawyer | Altrincham, United Kingdom | 12 |
| DR SAURABH SAHA | Company Director | Altrincham, United Kingdom | 12 |
| MS MARELLA THORELL | Accountant | Altrincham, United Kingdom | 11 |
| MR FRANCESCO DE RUBERTIS | Investor | London, United Kingdom | 15 |
| DR EMILIANGELO RATTI RATTI | Pharmaceutical Consultant | 37138 Verona, Italy | 2 |
| DAVID MIN CHAO | Chief Administrative Officer, Centessa Pharmaceuti | Altrincham, United Kingdom | 9 |
| RICHARD MENZIUSO | Controller | Altrincham, United Kingdom | 11 |
| AUSTIN KIM | Company Director | Cambridge, United Kingdom | 1 |
Nearby People
| Name | Occupation | Address | No of Appointments |
|---|---|---|---|
| MR NICHOLAS ALEXANDER JAMES TAIT | Company Director | Cambridge, England | 15 |
| PROFESSOR ANTHONY SEGAL | Professor | Cambridge, United Kingdom | 6 |
| JEANNE ELIZABETH BOLGER | Venture Investor | Cambridge, England | 1 |
| NITZAN ROSENFELD | Scientist | Cambridge, England | 1 |
| THE CAMBRIDGE PARTNERSHIP LIMITED | Cambridge, United Kingdom | 57 | |
| ALLAN BRADLEY | Professor And Chief Scientific Officer | Cambridge, United Kingdom | 6 |
| DR JILL RECKLESS | Company Director | Cambridge, England | 7 |
| CHRISTINE MARTIN | Technology Transfer Manager | Cambridge, United Kingdom | 6 |
| DR ELAINE MCKILLIGIN | Company Director | Cambridge, England | 8 |
| MR TIMOTHY SHANNON | Cambridge, England | 1 |